BrainSightAI is differentiated by its AI-driven connectome mapping from standard MRI data, serving a primarily Indian hospital network of 40+ institutions for surgical planning and psychiatric diagnostics. Its regional positioning in an underserved neurosurgery market gives it a distinct deployment context from US- and Europe-focused neuroimaging AI companies, though it limits near-term addressable market scale.